Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality

Detalles Bibliográficos
Autores principales: Polovina, Marija, Đjikić, Dijana, Vlajković, Ana, Vilotijević, Matej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2017
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689060/
https://www.ncbi.nlm.nih.gov/pubmed/28883311
http://dx.doi.org/10.14744/AnatolJCardiol.2017.7980
_version_ 1783279307505795072
author Polovina, Marija
Đjikić, Dijana
Vlajković, Ana
Vilotijević, Matej
author_facet Polovina, Marija
Đjikić, Dijana
Vlajković, Ana
Vilotijević, Matej
author_sort Polovina, Marija
collection PubMed
description
format Online
Article
Text
id pubmed-5689060
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-56890602017-11-21 Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality Polovina, Marija Đjikić, Dijana Vlajković, Ana Vilotijević, Matej Anatol J Cardiol Letter to the Editor Kare Publishing 2017-09 /pmc/articles/PMC5689060/ /pubmed/28883311 http://dx.doi.org/10.14744/AnatolJCardiol.2017.7980 Text en Copyright: © 2017 Turkish Society of Cardiology http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Letter to the Editor
Polovina, Marija
Đjikić, Dijana
Vlajković, Ana
Vilotijević, Matej
Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
title Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
title_full Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
title_fullStr Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
title_full_unstemmed Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
title_short Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
title_sort patients’ knowledge and perspectives on vitamin k antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689060/
https://www.ncbi.nlm.nih.gov/pubmed/28883311
http://dx.doi.org/10.14744/AnatolJCardiol.2017.7980
work_keys_str_mv AT polovinamarija patientsknowledgeandperspectivesonvitaminkantagonistsforstrokepreventioninatrialfibrillationimplicationsfortreatmentquality
AT đjikicdijana patientsknowledgeandperspectivesonvitaminkantagonistsforstrokepreventioninatrialfibrillationimplicationsfortreatmentquality
AT vlajkovicana patientsknowledgeandperspectivesonvitaminkantagonistsforstrokepreventioninatrialfibrillationimplicationsfortreatmentquality
AT vilotijevicmatej patientsknowledgeandperspectivesonvitaminkantagonistsforstrokepreventioninatrialfibrillationimplicationsfortreatmentquality

Ejemplares similares